Cardio-neuroprotection of anesthetic agents: recent clinical evidence and perspectives

Xin Li,Lize Xiong

DOI: https://doi.org/10.3760/cma.j.issn.1673-4378.2015.09.001

2015-01-01

Abstract:Background The cardio-neuroprotective effect of anesthetics has been widely concerned but still controversial.Although strong preclinical data support that anesthetics could attenuate ischemic/hypoxic myocardial and cerebral injury,confirmative conclusions have not been demonstrated from clinical studies.We reviewed clinical trials in recent years(especially randomized controlled trials) on cardio-neuroprotection of commonly used anesthetic agents (volatile anesthetics:isoflurane,sevoflurane,intravenous anesthetics:propofol,dexmedetomidine).Among the mostly studied anesthetics that reveal the property of cardio-neuroprotection,ether-derived volatile anesthetics have shown more promising potentials than intravenous anesthetics,especially in cardiac surgeries.The cardio-neuroprotection of intravenous anesthetic dexmedetomidine was validated in heart surgery by randomized controlled trial with large sample.However,the neuroprotection of anesthetic agents is controversial,and there's lack of simple and objective evaluation indicators for it.Thus,large-scale,multicenter clinical trials are necessary in the future.